EXTINA®—the first and only ketoconazole foam
for scalp, body, and face.*
EXTINA® Foam is a safe, effective prescription treatment for patients
12 years of age and older diagnosed with seborrheic dermatitis (seb derm).1 EXTINA® Foam is formulated with ketoconazole, a well-established
treatment for seb derm.
Available in a cosmetically elegant, patient-preferred foam vehicle, EXTINA® Foam
is the one ketoconazole formulation that treats seb derm on the scalp, body, and
face.* EXTINA® Foam applies easily on large and small affected areas,
including wet or dry hair-bearing or non–hair-bearing skin.1-3
*EXTINA® Foam is not for ophthalmic, oral, or intravaginal use.
Important safety information
EXTINA® (ketoconazole) Foam, 2% is indicated for the topical treatment
of seborrheic dermatitis in immunocompetent patients 12 years of age and older.
Safety and efficacy of EXTINA® Foam for treatment of fungal infections have not been
established.
The most common adverse reactions to EXTINA® Foam observed in clinical trials
(incidence >1%) were application site burning (10%) and application site reaction
(6%).
EXTINA® Foam may result in contact sensitization, including photoallergenicity.
EXTINA® Foam is not for ophthalmic, oral, or intravaginal use.
Full Prescribing Information for EXTINA® Foam
